Comparing the Sterility and Visibility of Surgical Marking Pens Available in Australia
Not Applicable
Completed
- Conditions
- Correct-site surgerySurgery - Other surgery
- Registration Number
- ACTRN12618001795280
- Lead Sponsor
- Edward O'Bryan
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 6
Inclusion Criteria
Fitzpatrick skin type 1 or 2
Minimal body hair on thighs
Exclusion Criteria
Allergy to surgical preparation liquids
Dermatitis
Broken skin on thighs
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pen ink visibility following surgical wash using Adobe Photoshop (Version 19.1.5.722).[Assessed one minute after surgical wash.]
- Secondary Outcome Measures
Name Time Method Pen tip sterility after patient contact. Swabs will be taken of the pen tip two minutes after final use. The swab will be sent to a pathology laboratory (Alfred Hospital, Melbourne) for culture and identification.[Two minutes after use.]
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms ensure sterility in surgical marking pens for correct-site surgery?
How do surgical marking pens compare to standard-of-care tools in preventing wrong-site surgeries?
Are there specific biomarkers that correlate with visibility persistence of surgical markers under varying conditions?
What adverse events are associated with surgical marking pen use in clinical settings and how are they managed?
What alternative compounds or technologies are being developed to enhance surgical site marking accuracy and sterility?